Skip to main content

Table 1 Correlations between SYNJ2BP expression and clinicopathological features of HCC

From: SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma

  

SYNJ2BP

 

Clinicopathologic Variables

n

Low expression

High expression

P Value a

Gender

    

 Male

84

32

52

 

 Female

14

7

7

0.399

Age (years)

    

 ≤ 60

71

28

43

 

 > 60

27

11

16

0.906

Hepatitis B status

    

 Negative

17

5

12

 

 Positive

81

34

47

0.336

AFP(ng/ml)

    

 <20

28

11

17

 

 ≥20

70

28

42

0.948

Liver cirrhosis

    

 Presence

81

5

12

 

 Absence

17

34

47

0.336

Tumor size (cm)

    

 ≤ 3

36

7

29

 

 >3

62

32

30

0.002

Tumor nodule number

    

 Single

47

7

40

 

 Multiple (≥2)

51

32

19

<0.001

Vascular invasion

    

 Presence

53

10

43

 

 Absence

45

29

16

<0.001

Child-Pugh classification

    

 A

76

31

45

 

 B

22

8

14

0.709

TNM stage

    

 I

40

8

32

 

 II

9

2

7

 

 III

49

29

20

<0.001

BCLC stage

    

 0-A

54

9

45

 

 B

9

4

5

 

 C

35

26

9

0.001

Edmonson-Steiner grade

    

 I-II

72

26

46

 

 III-IV

26

13

13

0.215

  1. Abbreviations: AFP alpha-fetoprotein, TNM tumor node metastasis, BCLC Barcelona Clinic Liver Cancer
  2. a Bold indicate statistical significance